MHRA Introduces New Device Registration Fee: What Manufacturers Need to Know
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has updated its “DORS Fees Guidance 2.1”, introducing a new annual fee model for device registration.
MedNet EC-REP
Author

From One-Time to Annual Fee
- Until 31 March 2026, MHRA continues to apply the existing £261 one-off registration fee.
- From 1 April 2026, a recurring annual fee will replace the one-off fee, based on the number of chargeable GMDN® Level 2 categories (or Level 1 if Level 2 is not defined).
- Fees will apply per category rather than per device, with pro-rata charges for new devices added mid-year.
Fee Calculation and Payment
- Annual fees are estimated at around £300 per GMDN category.
- MHRA will base fees on a snapshot of registered categories on 31 March each year.
- Payment is due within 90 days of invoicing, and non-payment may suspend registration access.
Changes and Exemptions
- Updating Letters of Designation, organisation name, or address will no longer incur fees.
- Re-registering devices in previously paid categories will not trigger additional charges.
- Only registration of new devices in chargeable categories triggers fees.
Preparing for the New System
Manufacturers and UK Responsible Persons should:
- Review device portfolios and ensure correct GMDN® category assignments before 30 March 2026.
- Verify contact and company information in the MHRA DORS system.
- Plan for the annual payment cycle, starting from 1 April 2026, and budget accordingly.
The shift to an annual fee model supports enhanced post-market surveillance, sustainable regulatory oversight, and encourages accurate device registrations.
Source: MHRA
Related Articles

EU Regulation 2026/977: What Medical Device Manufacturers Need to Know About New Notified Body Rules
The European Commission has adopted Commission Implementing Regulation (EU) 2026/977, introducing binding uniform rules on how notified bodies must handle quotations, conformity assessment timelines, and re-certification. For manufacturers of medical devices and in vitro diagnostic (IVD) medical devices, this regulation brings long-awaited predictability - and specific new compliance obligations.

MDCG 2025-10: New PMS Guidance for MDR & IVDR
The MDCG released new PMS guidance in December 2025. Learn what MDCG 2025-10 means for your MDR and IVDR compliance strategy.

EUDAMED’s first four modules become mandatory on 28 May 2026 - what this means for medical device manufacturers
The European Commission (EC) has formally declared that the first four modules of EUDAMED - the European Database on Medical Devices - will become mandatory as of 28 May 2026.
Stay Updated
Get the latest regulatory updates and industry insights delivered to your inbox.
Subscribe to Updates